Commit To Buy Regeneron Pharmaceuticals At $200, Earn 4.5% Using Options
February 08, 2018 at 14:00 PM EST
Investors eyeing a purchase of Regeneron Pharmaceuticals, Inc. (REGN) shares, but cautious about paying the going market price of $329.34/share, might benefit from considering selling puts among the alternative strategies at their disposal..